TY - JOUR
T1 - Are large clinical trials in orthopaedic trauma justified?
AU - on behalf of the FLOW Investigators
AU - Sprague, Sheila
AU - Tornetta, Paul
AU - Slobogean, Gerard P.
AU - O'Hara, Nathan N.
AU - McKay, Paula
AU - Petrisor, Brad
AU - Jeray, Kyle J.
AU - Schemitsch, Emil H.
AU - Sanders, David
AU - Bhandari, Mohit
AU - Guyatt, Gordon H.
AU - Walter, Stephen
AU - Anglen, Jeff
AU - Bosse, Michael
AU - Liew, Susan
AU - Sancheti, Parag
AU - Tai, Kerry
AU - Heels-Ansdell, Diane
AU - Buckingham, Lisa
AU - Duraikannan, Aravin
AU - Tanner, Stephanie L.
AU - Snider, Rebecca G.
AU - Altman, Douglas
AU - Gandhi, Rajiv
AU - Bischoff, Markus
AU - Della Rocca, Gregory J.
AU - Ristevski, Bill
AU - Rajaratnam, Krishan
AU - Williams, Dale
AU - Denkers, Matthew
AU - Bednar, Drew
AU - Sadler, John
AU - Kwok, Desmond
AU - Drew, Brian
AU - Wong, Ivan
AU - Madden, Kim
AU - Hall, Jeremy A.
AU - McKee, Michael D.
AU - Ahn, Henry
AU - Whelan, Daniel
AU - Waddell, James
AU - Daniels, Timothy
AU - Bogoch, Earl
AU - Nauth, Aaron
AU - Vicente, Milena R.
AU - Hidy, Jennifer T.
AU - Lawendy, Abdel Rahman
AU - Gurr, Kevin
AU - Carey, Timothy
AU - Hill, Austin D.
N1 - Funding Information:
The FLOW trial was supported by Research Grants from the Canadian Institutes of Health Research # MCT-93173, United States Army Institute of Surgical Research, Orthopaedic Trauma Research Program (OTRP) and Peer Reviewed Orthopaedic Research Program (PRORP), and Association Internationale pour l’Ostéosynthèse Dynamique (AIOD). Stryker Company provided Surgilav irrigators for the trial for clinical sites in Asia. Zimmer Company provided the Pulsavac irrigator at discounted rates to selected clinical sites in North America. Triad Medical donated the initial supply of castile soap for the study. No donor or funder had a role in the design or conduct of the FLOW study, data collection or analyses, or the preparation of this manuscript. The FLOW trial was supported by the Office of the Assistant Secretary of Defense for Health Affairs, through the Orthopaedic Trauma Research Program under Award No. W81XWH-08-1-0473 and the Peer Reviewed Orthopaedic Research Program under Award No. W81XWH-12-1-0530. Opinions, interpretations, conclusions and recommendations are those of the authors and are not necessarily endorsed by the Department of Defense.
Funding Information:
SS reports grants from the Canadian Institutes of Health Research, employment/salary from McMaster University, and employment/salary from Global Research Solutions outside the submitted work. PTIII reports other from Smith & Nephew and other from Lippincott Williams & Wilkins outside the submitted work. PM reports personal fees from Global Research Solutions outside the submitted work. BP reports grants from Stryker, outside the submitted work. KJJ reports personal fees from Zimmer, personal fees from Lilly USA, LLC, and personal fees from Pacira outside the submitted work. MB reports grants from Canadian Institutes of Health Research, other from Stryker, other from Zimmer, other from Triad Medical, grants from Office of the Assistant Secretary of Defense for Health Affairs through the Orthopaedic Trauma Research Program and the Peer Reviewed Orthopaedic Research Program, and grants from Association Internationale pour l’Osteosynthese Dynamique during the conduct of the study. He reports grants and personal fees from Stryker, personal fees from Smith & Nephew, grants and personal fees from Amgen, grants from DePuy, grants and personal fees from Eli Lilly, grants and personal fees from DJO Global Inc., personal fees from Zimmer, and personal fees from Ferring outside the submitted work. GPS, NNO, and DS have nothing to disclose.
Publisher Copyright:
© 2018 The Author(s).
PY - 2018/4/20
Y1 - 2018/4/20
N2 - Background: The objective of this analysis is to evaluate the necessity of large clinical trials using FLOW trial data. Methods: The FLOW pilot study and definitive trial were factorial trials evaluating the effect of different irrigation solutions and pressures on re-operation. To explore treatment effects over time, we analyzed data from the pilot and definitive trial in increments of 250 patients until the final sample size of 2447 patients was reached. At each increment we calculated the relative risk (RR) and associated 95% confidence interval (CI) for the treatment effect, and compared the results that would have been reported at the smaller enrolments with those seen in the final, adequately powered study. Results: The pilot study analysis of 89 patients and initial incremental enrolments in the FLOW definitive trial favored low pressure compared to high pressure (RR: 1.50, 95% CI: 0.75-3.04; RR: 1.39, 95% CI: 0.60-3.23, respectively), which is in contradiction to the final enrolment, which found no difference between high and low pressure (RR: 1.04, 95% CI: 0.81-1.33). In the soap versus saline comparison, the FLOW pilot study suggested that re-operation rate was similar in both the soap and saline groups (RR: 0.98, 95% CI: 0.50-1.92), whereas the FLOW definitive trial found that the re-operation rate was higher in the soap treatment arm (RR: 1.28, 95% CI: 1.04-1.57). Conclusions: Our findings suggest that studies with smaller sample sizes would have led to erroneous conclusions in the management of open fracture wounds. Trial registration: NCT01069315 (FLOW Pilot Study) Date of Registration: February 17, 2010, NCT00788398 (FLOW Definitive Trial) Date of Registration: November 10, 2008.
AB - Background: The objective of this analysis is to evaluate the necessity of large clinical trials using FLOW trial data. Methods: The FLOW pilot study and definitive trial were factorial trials evaluating the effect of different irrigation solutions and pressures on re-operation. To explore treatment effects over time, we analyzed data from the pilot and definitive trial in increments of 250 patients until the final sample size of 2447 patients was reached. At each increment we calculated the relative risk (RR) and associated 95% confidence interval (CI) for the treatment effect, and compared the results that would have been reported at the smaller enrolments with those seen in the final, adequately powered study. Results: The pilot study analysis of 89 patients and initial incremental enrolments in the FLOW definitive trial favored low pressure compared to high pressure (RR: 1.50, 95% CI: 0.75-3.04; RR: 1.39, 95% CI: 0.60-3.23, respectively), which is in contradiction to the final enrolment, which found no difference between high and low pressure (RR: 1.04, 95% CI: 0.81-1.33). In the soap versus saline comparison, the FLOW pilot study suggested that re-operation rate was similar in both the soap and saline groups (RR: 0.98, 95% CI: 0.50-1.92), whereas the FLOW definitive trial found that the re-operation rate was higher in the soap treatment arm (RR: 1.28, 95% CI: 1.04-1.57). Conclusions: Our findings suggest that studies with smaller sample sizes would have led to erroneous conclusions in the management of open fracture wounds. Trial registration: NCT01069315 (FLOW Pilot Study) Date of Registration: February 17, 2010, NCT00788398 (FLOW Definitive Trial) Date of Registration: November 10, 2008.
KW - FLOW trial
KW - Large trials
KW - Orthopaedic trial
KW - Sample size
UR - http://www.scopus.com/inward/record.url?scp=85045936005&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85045936005&partnerID=8YFLogxK
U2 - 10.1186/s12891-018-2029-3
DO - 10.1186/s12891-018-2029-3
M3 - Article
C2 - 29678204
AN - SCOPUS:85045936005
SN - 1471-2474
VL - 19
SP - 124
JO - BMC Musculoskeletal Disorders
JF - BMC Musculoskeletal Disorders
IS - 1
M1 - 124
ER -